Why These 24 Stocks Are Skyrocketing

Page 21 of 23

3. Scholar Rock Holding Corporation (NASDAQ:SRRK)

Q4 Returns as of December 31, 2024: 440%

In Q4 2024, SRRK’s stock price returned nearly 440%, going from $8.01 on September 30 to $43.22 on December 31, 2024. The increase can be attributed to its expanding position in its underlying biotechnology prowess and growing drug portfolio.

Not only does the Street weigh positively on the stock, but analyst firm Wedbush also raised its target price for SRRK to $50 from $40 earlier, while HC Wainwright & Co. increased its price target to $47 from $40.

SRRK is expected to carry momentum, which is evident from its research and development allocated to drug discovery and development. Aligning with its goal, Scholar Rock Holding Corp (SRRK) completed several trials in the third quarter of 2024 and reported positive data from the Phase 3 trials of its leading drug, SAPPHIRE.

Page 21 of 23